CYC vs MVF

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

41LOW

MVF

MONASH IVF FPO [MVF]

38LOW

Score Breakdown

CYC MVF
Technical
41
60
Catalyst
51
51
Sentiment
50
50
Fundamental
69
68
Momentum
39
52
Risk Gate
50
39

Key Metrics

CYC Metric MVF
$61.6MMarket Cap$278.6M
345KAvg Volume (20d)728K
N/AShort Interest+1.6%
$1.29052-Week High$0.895
$0.45052-Week Low$0.575
-6.7%Daily Change+0.0%
$0.490Reference Price$0.710
-49.3%ROE+6.2%
-53.3%Profit Margin+5.6%

Active Signals

CYC Signals

●RSI drifting toward oversold territory — worth watching
●Volume surging at 2.7x normal while price falls — heavy selling pressure
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (1.9x)
●Moderate revenue growth (+10%)
●EPS estimates revised upward (+10pts)

MVF Signals

●MACD just crossed bullish — momentum is shifting to the upside
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.0x)
●EPS estimates revised upward (+10pts)
●Post-earnings drift: negative surprise (SUE -10)
●Earnings in sharp decline (-58% QoQ)

Ask Scout AI to compare CYC and MVF in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CYC vs NEU →CYC vs PHX →CYC vs PKY →CYC vs REG →CYC vs RHY →
CYC Full Analysis → MVF Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).